Logo image of SANG

SANGOMA TECHNOLOGIES CORP (SANG) Stock Fundamental Analysis

USA - NASDAQ:SANG - CA80100R4089 - Common Stock

5.07 USD
-0.06 (-1.17%)
Last: 11/20/2025, 8:25:11 PM
Fundamental Rating

3

Taking everything into account, SANG scores 3 out of 10 in our fundamental rating. SANG was compared to 48 industry peers in the Communications Equipment industry. SANG may be in some trouble as it scores bad on both profitability and health. SANG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SANG had negative earnings in the past year.
SANG had a positive operating cash flow in the past year.
In the past 5 years SANG reported 4 times negative net income.
SANG had a positive operating cash flow in each of the past 5 years.
SANG Yearly Net Income VS EBIT VS OCF VS FCFSANG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

SANG has a Return On Assets (-1.45%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -1.97%, SANG is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -1.45%
ROE -1.97%
ROIC N/A
ROA(3y)-3.39%
ROA(5y)-6.47%
ROE(3y)-5.4%
ROE(5y)-10.77%
ROIC(3y)N/A
ROIC(5y)N/A
SANG Yearly ROA, ROE, ROICSANG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

SANG's Gross Margin of 68.34% is amongst the best of the industry. SANG outperforms 93.75% of its industry peers.
In the last couple of years the Gross Margin of SANG has remained more or less at the same level.
SANG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y1.11%
SANG Yearly Profit, Operating, Gross MarginsSANG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

SANG does not have a ROIC to compare to the WACC, probably because it is not profitable.
SANG has less shares outstanding than it did 1 year ago.
SANG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SANG has been reduced compared to a year ago.
SANG Yearly Shares OutstandingSANG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
SANG Yearly Total Debt VS Total AssetsSANG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

SANG has an Altman-Z score of 1.15. This is a bad value and indicates that SANG is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SANG (1.15) is comparable to the rest of the industry.
The Debt to FCF ratio of SANG is 1.70, which is an excellent value as it means it would take SANG, only 1.70 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 1.70, SANG is doing good in the industry, outperforming 70.83% of the companies in the same industry.
A Debt/Equity ratio of 0.13 indicates that SANG is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.13, SANG is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.7
Altman-Z 1.15
ROIC/WACCN/A
WACC8.25%
SANG Yearly LT Debt VS Equity VS FCFSANG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

SANG has a Current Ratio of 0.86. This is a bad value and indicates that SANG is not financially healthy enough and could expect problems in meeting its short term obligations.
SANG has a Current ratio of 0.86. This is amonst the worse of the industry: SANG underperforms 93.75% of its industry peers.
A Quick Ratio of 0.70 indicates that SANG may have some problems paying its short term obligations.
SANG's Quick ratio of 0.70 is on the low side compared to the rest of the industry. SANG is outperformed by 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.7
SANG Yearly Current Assets VS Current LiabilitesSANG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.00% over the past year.
Looking at the last year, SANG shows a decrease in Revenue. The Revenue has decreased by -4.28% in the last year.
Measured over the past years, SANG shows a quite strong growth in Revenue. The Revenue has been growing by 19.31% on average per year.
EPS 1Y (TTM)36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)-4.28%
Revenue growth 3Y1.79%
Revenue growth 5Y19.31%
Sales Q2Q%-15.51%

3.2 Future

Based on estimates for the next years, SANG will show a very strong growth in Earnings Per Share. The EPS will grow by 63.09% on average per year.
Based on estimates for the next years, SANG will show a decrease in Revenue. The Revenue will decrease by -3.99% on average per year.
EPS Next Y19.2%
EPS Next 2Y63.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.77%
Revenue Next 2Y-3.99%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SANG Yearly Revenue VS EstimatesSANG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
SANG Yearly EPS VS EstimatesSANG Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

3

4. Valuation

4.1 Price/Earnings Ratio

SANG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
SANG is valuated quite expensively with a Price/Forward Earnings ratio of 51.22.
62.50% of the companies in the same industry are cheaper than SANG, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SANG to the average of the S&P500 Index (34.08), we can say SANG is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 51.22
SANG Price Earnings VS Forward Price EarningsSANG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SANG is valued cheaply inside the industry as 97.92% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than SANG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.12
EV/EBITDA 4.82
SANG Per share dataSANG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SANG's earnings are expected to grow with 63.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y63.09%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SANG!.
Industry RankSector Rank
Dividend Yield N/A

SANGOMA TECHNOLOGIES CORP

NASDAQ:SANG (11/20/2025, 8:25:11 PM)

5.07

-0.06 (-1.17%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)02-03 2026-02-03
Inst Owners34.91%
Inst Owner Change-7.36%
Ins Owners27.21%
Ins Owner ChangeN/A
Market Cap168.58M
Revenue(TTM)236.69M
Net Income(TTM)-5.01M
Analysts80
Price Target7.77 (53.25%)
Short Float %0.1%
Short Ratio2.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)281.52%
Min EPS beat(2)-32.01%
Max EPS beat(2)595.05%
EPS beat(4)1
Avg EPS beat(4)89.5%
Min EPS beat(4)-197.03%
Max EPS beat(4)595.05%
EPS beat(8)2
Avg EPS beat(8)2.25%
EPS beat(12)5
Avg EPS beat(12)12.48%
EPS beat(16)6
Avg EPS beat(16)-258.64%
Revenue beat(2)1
Avg Revenue beat(2)-1.04%
Min Revenue beat(2)-2.42%
Max Revenue beat(2)0.34%
Revenue beat(4)1
Avg Revenue beat(4)-3.25%
Min Revenue beat(4)-7.66%
Max Revenue beat(4)0.34%
Revenue beat(8)2
Avg Revenue beat(8)-2.22%
Revenue beat(12)3
Avg Revenue beat(12)-2.89%
Revenue beat(16)7
Avg Revenue beat(16)0.74%
PT rev (1m)-0.48%
PT rev (3m)-3.03%
EPS NQ rev (1m)-40%
EPS NQ rev (3m)-86.67%
EPS NY rev (1m)-349.94%
EPS NY rev (3m)-185.71%
Revenue NQ rev (1m)-2.76%
Revenue NQ rev (3m)-14.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-14.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 51.22
P/S 0.71
P/FCF 5.12
P/OCF 4.03
P/B 0.66
P/tB N/A
EV/EBITDA 4.82
EPS(TTM)-0.16
EYN/A
EPS(NY)0.1
Fwd EY1.95%
FCF(TTM)0.99
FCFY19.54%
OCF(TTM)1.26
OCFY24.79%
SpS7.12
BVpS7.64
TBVpS-0.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.45%
ROE -1.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.34%
FCFM 13.92%
ROA(3y)-3.39%
ROA(5y)-6.47%
ROE(3y)-5.4%
ROE(5y)-10.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y1.11%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.7
Debt/EBITDA 0.78
Cap/Depr 19.62%
Cap/Sales 3.73%
Interest Coverage N/A
Cash Conversion 95.46%
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.7
Altman-Z 1.15
F-Score6
WACC8.25%
ROIC/WACCN/A
Cap/Depr(3y)22.92%
Cap/Depr(5y)19.53%
Cap/Sales(3y)4.2%
Cap/Sales(5y)3.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y19.2%
EPS Next 2Y63.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.28%
Revenue growth 3Y1.79%
Revenue growth 5Y19.31%
Sales Q2Q%-15.51%
Revenue Next Year-12.77%
Revenue Next 2Y-3.99%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2383.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.16%
FCF growth 3Y27.36%
FCF growth 5Y36.51%
OCF growth 1Y-5.56%
OCF growth 3Y25.66%
OCF growth 5Y36.31%

SANGOMA TECHNOLOGIES CORP / SANG FAQ

What is the fundamental rating for SANG stock?

ChartMill assigns a fundamental rating of 3 / 10 to SANG.


Can you provide the valuation status for SANGOMA TECHNOLOGIES CORP?

ChartMill assigns a valuation rating of 3 / 10 to SANGOMA TECHNOLOGIES CORP (SANG). This can be considered as Overvalued.


What is the profitability of SANG stock?

SANGOMA TECHNOLOGIES CORP (SANG) has a profitability rating of 3 / 10.


Can you provide the financial health for SANG stock?

The financial health rating of SANGOMA TECHNOLOGIES CORP (SANG) is 3 / 10.